Skip to main content

Bonita David P's Form 4 filing

Repare Therapeutics Inc. (RPTX) · filed Aug 30, 2021

Accession no.
0000947871-21-000967
Filed
Aug 30, 2021
Trade date
Aug 26-30, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market sales total $615.7K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bonita David PCIK 0001572451Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 26, 2021Common StockSSaleDisposed−4,157$34.52−$143,499.643,235,021Indirect
Aug 26, 2021Common StockSSaleDisposed−126$34.52−$4,349.5297,948Indirect
Aug 27, 2021Common StockSSaleDisposed−6,884$33.94−$233,642.963,228,137Indirect
Aug 27, 2021Common StockSSaleDisposed−209$33.94−$7,093.4697,739Indirect
Aug 30, 2021Common StockSSaleDisposed−6,500$33.92−$220,4803,221,637Indirect
Aug 30, 2021Common StockSSaleDisposed−197$33.92−$6,682.2497,542Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)